Abstract |
Pancytopenia occurring after bone marrow transplantation is a rare complication. A 47 year old patient with progression of multiple myeloma after standard therapy received an allogeneic marrow graft from a matched unrelated donor. The non-myeloablative conditioning regimen consisted of fludarabine, cyclophosphamide, rabbit anti-thymocyte globulin and total body irradiation. GVHD prophylaxis consisted of cyclosporine. Neutrophil engraftment was as expected and the patient was discharged without signs of acute GvHD. On day +34 the patient presented with clinical and laboratory findings consistent with severe pancytopenia. Antibodies against red cells, platelets, lymphocytes and granulocytes were detected in extremely high titers. Immune-mediated pancytopenia was refractory on multiple immunosuppressive treatment strategies. Proliferation of polyclonal plasma cells of recipient-type that was documented postmortem, was most likely responsible for excessive antibody formation.
|
Authors | Stefan Knop, Juergen Bux, Stefan M Kroeber, Peter Bader, Holger Hebart, Lothar Kanz, Hermann Einsele |
Journal | Haematologica
(Haematologica)
Vol. 89
Issue 5
Pg. ECR12
(May 2004)
ISSN: 1592-8721 [Electronic] Italy |
PMID | 15136241
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Autoantibodies
- HLA Antigens
|
Topics |
- Anemia, Hemolytic, Autoimmune
(immunology)
- Animals
- Autoantibodies
(blood)
- Blood Cells
(immunology)
- Bone Marrow Transplantation
(adverse effects, immunology)
- Fatal Outcome
- HLA Antigens
(immunology)
- Histocompatibility
- Humans
- Male
- Middle Aged
- Multiple Myeloma
(immunology, therapy)
- Pancytopenia
(immunology)
- Rabbits
- Respiratory Distress Syndrome
(immunology)
- Transplantation Conditioning
(methods)
- Transplantation, Homologous
|